OTCM
MDNXF
Market cap23mUSD
, Last price
USD
Name
Medinex Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four main segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. Within its Medical Support Services division, Medinex assists with clinic establishment, streamlines license applications, delivers value-added solutions for the healthcare sector, offers comprehensive turnkey solutions, and provides strategic guidance to general practitioners and specialists on setting up their facilities. The Business Support Services segment extends its offerings beyond the medical field, supplying crucial administrative support such as accounting, tax agency, human resource management, and corporate secretarial services to a variety of sectors including food and beverage, retail, education, and beauty. Through its Pharmaceutical Services, Medinex manages the sourcing and supply of medical and pharmaceutical products to clinics. The Medical Services segment directly furnishes a range of clinical provisions, including diagnostic imaging and x-rays, pre-employment health examinations, vaccination programs, customized healthcare plans, and general health screenings. Furthermore, Medinex offers advisory and business management consultancy, call support services, data protection officer roles, and various training programs to its clients.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||